Scientists Uncover Brain Cell Defenses Against Alzheimer's Protein

New research reveals how certain neurons resist toxic tau buildup, pointing to potential treatment strategies.

Feb. 4, 2026 at 1:55am by Ben Kaplan

Got story updates? Submit your updates here. ›

Researchers at UCLA Health and UC San Francisco have discovered why some brain cells are more resilient than others to the buildup of tau protein, a hallmark of Alzheimer's disease and related dementias. Using a novel CRISPR-based genetic screening approach on lab-grown human neurons, the team identified a protein complex called CRL5SOCS4 that marks tau for degradation, suggesting that strengthening this natural defense mechanism could represent a new therapeutic strategy.

Why it matters

Tau is the most common protein that aggregates in neurodegenerative diseases, but researchers had not determined why some types of neurons are affected more than others. Understanding the cellular machinery that controls tau accumulation could lead to new treatments for Alzheimer's and other dementias, which currently have no effective therapies.

The details

The researchers used CRISPR gene-editing technology in neurons derived from human stem cells to systematically test how knocking down individual genes affected the buildup of toxic tau clumps. They found that the CRL5SOCS4 protein complex marks tau for destruction by the cell's recycling machinery. Analysis of brain tissue from Alzheimer's patients also revealed that higher expression of CRL5SOCS4 components made neurons more likely to survive despite tau accumulation.

  • The study was published in the journal Cell on February 4, 2026.

The players

Dr. Avi Samelson

Assistant professor of Neurology at UCLA Health, who conducted the research while at UCSF.

UCLA Health

A medical center and research institution that collaborated on the study.

UC San Francisco

A university and medical center that collaborated on the study.

Got photos? Submit your photos here. ›

What they’re saying

“We wanted to understand why some neurons are vulnerable to tau accumulation while others are more resilient. By systematically screening nearly every gene in the human genome, we found both expected pathways and completely unexpected ones that control tau levels in neurons.”

— Dr. Avi Samelson, Assistant professor of Neurology at UCLA Health (Mirage News)

“What makes this study particularly valuable is that we used human neurons carrying an actual disease-causing mutation. These cells naturally have differences in tau processing, giving us confidence that the mechanisms we identified are relevant to human disease.”

— Dr. Avi Samelson, Assistant professor of Neurology at UCLA Health (Mirage News)

What’s next

The researchers emphasized that translating these discoveries into treatments will require additional research.

The takeaway

The findings provide promising leads for therapeutic development, as enhancing the CRL5SOCS4 protein complex's ability to mark tau for degradation and maintaining the cell's protein recycling machinery could help neurons clear toxic tau more effectively, potentially leading to new treatments for Alzheimer's and other neurodegenerative diseases.